Abemaciclib With or Without Atezolizumab for mCRPC

Clinical trial NCT04751929 · COMPLETED

Trial details

NCT number: NCT04751929
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2021-08-20
Primary completion: 2024-06-17
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.